U.S. drug overdose deaths drop 27% as naloxone access expands

U.S. drug overdose deaths fell 27% in 2024, with preliminary 2025 data showing another significant drop, marking an unprecedented decline after years of record-high fatalities. Similar reductions occurred in Scotland and Canada, though mortality rates remain elevated. Experts attribute the decline to multiple factors, including wider naloxone distribution, expanded access to opioid use disorder medications, improved prison treatment, and better data systems. Virginia saw a 40% decrease after implementing a naloxone saturation plan, while Maryland's doubled distribution coincided with a 25% drop. The drug supply's changing potency and high prior death rates may also contribute. However, progress faces threats from Medicaid cuts and federal funding reductions, with experts warning that 156,000 people could lose opioid treatment access, potentially doubling overdose rates among that group.